JP2015509939A5 - - Google Patents

Download PDF

Info

Publication number
JP2015509939A5
JP2015509939A5 JP2014557781A JP2014557781A JP2015509939A5 JP 2015509939 A5 JP2015509939 A5 JP 2015509939A5 JP 2014557781 A JP2014557781 A JP 2014557781A JP 2014557781 A JP2014557781 A JP 2014557781A JP 2015509939 A5 JP2015509939 A5 JP 2015509939A5
Authority
JP
Japan
Prior art keywords
formula
compound
group
alkyl
organic solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014557781A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015509939A (ja
JP6147279B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/026204 external-priority patent/WO2013123240A1/en
Publication of JP2015509939A publication Critical patent/JP2015509939A/ja
Publication of JP2015509939A5 publication Critical patent/JP2015509939A5/ja
Application granted granted Critical
Publication of JP6147279B2 publication Critical patent/JP6147279B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014557781A 2012-02-17 2013-02-14 オレキシン−2受容体アンタゴニストの合成において有用な方法および化合物 Active JP6147279B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261600109P 2012-02-17 2012-02-17
US61/600,109 2012-02-17
PCT/US2013/026204 WO2013123240A1 (en) 2012-02-17 2013-02-14 Methods and compounds useful in the synthesis of orexin-2 receptor antagonists

Publications (3)

Publication Number Publication Date
JP2015509939A JP2015509939A (ja) 2015-04-02
JP2015509939A5 true JP2015509939A5 (cg-RX-API-DMAC7.html) 2016-03-31
JP6147279B2 JP6147279B2 (ja) 2017-06-14

Family

ID=47755050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014557781A Active JP6147279B2 (ja) 2012-02-17 2013-02-14 オレキシン−2受容体アンタゴニストの合成において有用な方法および化合物

Country Status (13)

Country Link
US (3) US9416109B2 (cg-RX-API-DMAC7.html)
EP (1) EP2814798B1 (cg-RX-API-DMAC7.html)
JP (1) JP6147279B2 (cg-RX-API-DMAC7.html)
CN (1) CN104114524B (cg-RX-API-DMAC7.html)
BR (1) BR112014019909B1 (cg-RX-API-DMAC7.html)
CA (1) CA2861493C (cg-RX-API-DMAC7.html)
ES (1) ES2733750T3 (cg-RX-API-DMAC7.html)
HU (1) HUE043995T2 (cg-RX-API-DMAC7.html)
IL (1) IL232949A (cg-RX-API-DMAC7.html)
MX (1) MX352881B (cg-RX-API-DMAC7.html)
RU (1) RU2617696C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201403216UA (cg-RX-API-DMAC7.html)
WO (1) WO2013123240A1 (cg-RX-API-DMAC7.html)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013119639A1 (en) 2012-02-07 2013-08-15 Eolas Therapeutics, Inc. Substituted prolines / piperidines as orexin receptor antagonists
US9440982B2 (en) 2012-02-07 2016-09-13 Eolas Therapeutics, Inc. Substituted prolines/piperidines as orexin receptor antagonists
EP2814798B1 (en) * 2012-02-17 2019-04-03 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of orexin-2 receptor antagonists
ES2731648T3 (es) 2014-08-06 2019-11-18 Eisai R&D Man Co Ltd Método para producir un compuesto de pirimidina-1-ol y compuesto intermedio del mismo
US10221170B2 (en) 2014-08-13 2019-03-05 Eolas Therapeutics, Inc. Difluoropyrrolidines as orexin receptor modulators
DK3414241T3 (da) 2016-02-12 2022-08-01 Astrazeneca Ab Halogensubstituerede piperidiner som orexinreceptormodulatorer
CN115710250A (zh) * 2017-08-01 2023-02-24 博健制药有限责任公司 一种食欲素受体拮抗剂的晶型及其制备方法和用途
GB201807898D0 (en) * 2018-05-15 2018-06-27 Kancera Ab New processes and products with increased chiral purity
JP7384810B2 (ja) * 2018-09-07 2023-11-21 住友化学株式会社 シクロプロパン化合物の製造方法
EP4506325A3 (en) * 2019-05-15 2025-04-30 Eisai R&D Management Co., Ltd. Method and compound useful in preparation of orexin-2 receptor antagonist, and lemborexant having few impurities
EP3983370B1 (en) 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
US12209065B2 (en) 2019-06-12 2025-01-28 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
WO2020249688A1 (en) 2019-06-12 2020-12-17 Nouryon Chemicals International B.V. Process for the production of diacyl peroxides
HUE063678T2 (hu) 2019-06-12 2024-01-28 Nouryon Chemicals Int Bv Eljárás peroxiészterek elõállítására
EP3983340B1 (en) * 2019-06-12 2023-08-02 Nouryon Chemicals International B.V. Method for isolating carboxylic acid from an aqueous side stream
WO2020263253A1 (en) * 2019-06-26 2020-12-30 Moline Margaret Lemborexant for treating sleep issues
EP4073058A1 (en) 2019-12-11 2022-10-19 Teva Czech Industries s.r.o. Solid state form of lemborexant
US20230051268A1 (en) 2019-12-20 2023-02-16 Eisai R&D Management Co., Ltd. Use of lemborexant for treating insomnia
MX2022008260A (es) 2020-01-16 2022-08-04 Eisai R&D Man Co Ltd Sustancia farmacologica de lemborexant y composicion medicinal que la comprende.
ES2933074B2 (es) 2021-07-26 2023-09-29 Moehs Iberica Sl Procedimiento de sintesis de 2,4-dimetilpirimidin-5-ol, nuevos intermedios de dicho procedimiento y uso del producto en la sintesis de lemborexant
WO2023178693A1 (zh) * 2022-03-25 2023-09-28 浙江华海药业股份有限公司 一种莱博雷生及其中间体的制备方法
CN118843622A (zh) * 2022-03-25 2024-10-25 浙江华海药业股份有限公司 莱博雷生及其中间体化合物的制备方法
CN114778745B (zh) * 2022-06-21 2022-09-16 南京威凯尔生物医药科技有限公司 一种高效液相色谱法检测仑布雷生中间体及其对映体杂质的方法
CN119930526B (zh) * 2025-04-07 2025-07-08 东北制药集团股份有限公司 一种莱博雷生中间体的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2302994A1 (fr) * 1975-03-06 1976-10-01 Fabre Sa Pierre Procede de preparation d'acides aryl-1, hydroxy methyl-2 cyclopropanes carboxyliques et de leurs lactones utiles comme intermediaires de synthese dans l'industrie pharmaceutique
US5849954A (en) * 1996-01-18 1998-12-15 Research Corporation Technologies, Inc. Method of peptide synthesis
WO2004037212A2 (en) 2002-10-24 2004-05-06 Sepracor, Inc. Compositions comprising zopiclone derivatives and methods of making and using the same
US8138377B2 (en) * 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
PL2152690T3 (pl) * 2007-05-23 2012-06-29 Merck Sharp & Dohme Pirydylo piperydynowi antagoniści receptora oreksyny
CA2687230A1 (en) * 2007-05-23 2008-12-11 Merck & Co., Inc. Cyclopropyl pyrrolidine orexin receptor antagonists
AP2011005611A0 (en) 2008-09-18 2011-04-30 Pfizer Ltd Amide compounds useful in therapy.
KR20110091581A (ko) 2008-12-02 2011-08-11 글락소 그룹 리미티드 N-{[1r,4s,6r-3-(2-피리디닐카르보닐)-3-아자비시클로[4.1.0]헵트-4-일]메틸}-2-헤테로아릴아민 유도체 및 그의 용도
FR2941454B1 (fr) * 2009-01-29 2011-04-01 Pf Medicament Proced de synthese du (1s,2r)-milnacipran
US8101643B2 (en) 2009-02-27 2012-01-24 Enanta Pharmaceuticals, Inc. Benzimidazole derivatives
BRPI1013264A2 (pt) 2009-03-09 2016-04-05 Novozymes As processo para reduzir o teor de glicosídeo esteroidal em uma composição, e, uso do processo
CN103153963B (zh) * 2010-09-22 2014-12-24 卫材R&D管理有限公司 环丙烷化合物
EP2814798B1 (en) * 2012-02-17 2019-04-03 Eisai R&D Management Co., Ltd. Methods and compounds useful in the synthesis of orexin-2 receptor antagonists

Similar Documents

Publication Publication Date Title
JP2015509939A5 (cg-RX-API-DMAC7.html)
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
RU2009105669A (ru) Способ получения 3-замещенных 2-амино-5-галогенбензамидов
KR101934096B1 (ko) 이델라리십의 제조방법
RU2016133187A (ru) Способ получения n-[(3-аминооксетан-3-ил)метил]-2-(1,1-диоксо-3,5-дигидро-1,4-бензотиазепин-4ил)-6-метил-хиназолин-4-амина
JP2009543861A5 (cg-RX-API-DMAC7.html)
JP2008523069A5 (cg-RX-API-DMAC7.html)
JP2006143746A5 (cg-RX-API-DMAC7.html)
JP2007523139A5 (cg-RX-API-DMAC7.html)
PE20100051A1 (es) Nuevo procedimiento de sintesis de 7,8-dimetoxi-1,3-dihidro-2h-3-benzazepin-2-oa y aplicacion en la sintesis de ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable
JP2013249315A5 (cg-RX-API-DMAC7.html)
JP2012121931A5 (cg-RX-API-DMAC7.html)
RU2010141941A (ru) Способ получения фторсодержащего производного ацилуксусной кислоты, способ получения фторсодержащего производного сложного эфира пиразолкарбоновой кислоты и способ получения фторсодержащего пиразолкарбоновой кислоты
JP2017522357A5 (cg-RX-API-DMAC7.html)
RU2011131067A (ru) Стабильные инсектицидные композиции и способы их получения
CA2587528A1 (en) Method for preparing n-phenylpyrazole-1-carboxamides
RU2008109650A (ru) Способ получения бетамиметиков
CO6270260A2 (es) Metodos para producir 2`-desoxi-5-azacitidina (decitabina)
RU2015126911A (ru) Способ получения 1-([1,3]диоксолан-4-илметил)-1н-пиразол-3-иламина
RU2012142172A (ru) Азотсодержащее гетероциклическое соединение и способ его получения
JP2013531058A5 (cg-RX-API-DMAC7.html)
JP2014520781A5 (cg-RX-API-DMAC7.html)
HRP20080510T3 (hr) Postupak za priređivanje optički aktivnih derivata 2-(2-piridilmetilsulfinil)-benzimidazola putem inkluzijskog kompleksa s 1,1'-binaftalen-2,2' diolom
RU2015129994A (ru) Способ получения 1-(4-(4-(3, 4-дихлор-2-фторфениламино)-7-метоксихиназолин-6-илокси)пиперидин-1-ил)проп-2-ен-1-она
JP2014516968A5 (cg-RX-API-DMAC7.html)